Home › Funds › 22NW, LP › RGNX

22NW, LP position in RGNX

REGENXBIO INC · Health Care

22NW, LP reported holding 492,759 shares of RGNX (REGENXBIO INC) in its Q2 2026 13F filing — a position valued at US$5.9M, representing 5.64% of its reported portfolio and ranking #6 among its reported holdings. 22NW, LP has disclosed RGNX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)492.76K sh
Reported value held$5.90M
Portfolio Weight5.64%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 22NW, LP's RGNX position evolved

22NW, LP first disclosed a stake in RGNX in Q1 2025 at 668,679 shares (US$4.8M). The position peaked in Q4 2025 at 923,679 shares, worth US$13.3M. Across 6 filings, 22NW, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 492,759 shares valued at US$5.9M. Notable position changes include a 38% increase in Q2 2025 (shares rose 18% over the following quarter), a 47% trim in Q1 2026 (shares rose 43% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 668.68K $4.78M New
Q2 2025 923.68K $7.58M Add
Q3 2025 923.68K $8.91M Hold
Q4 2025 923.68K $13.30M Hold
Q1 2026 492.76K $4.13M Reduce
Q2 2026 492.76K $5.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGNX and 13F data

RGNX (REGENXBIO INC) is a Health Care company. 33 other funds we track also report a position in RGNX — the largest reported positions include Redmile Group, LLC (US$52.3M), Pale Fire Capital SE (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGNX

All RGNX fund holders →

FAQ

How long has 22NW, LP held RGNX?

22NW, LP has disclosed RGNX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is 22NW, LP's current position in RGNX?

As of Q2 2026, 22NW, LP holds 492.76K shares of RGNX (REGENXBIO INC), valued at $5.90M, representing 5.64% of its reported portfolio and ranking #6.

Has 22NW, LP been buying or selling RGNX?

In the latest 13F filing (Q2 2026), 22NW, LP held unchanged its position in RGNX. The position peaked in Q4 2025 at 923.68K shares.

Which other funds hold RGNX?

Other major institutional holders of RGNX include Redmile Group, LLC, Pale Fire Capital SE, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.